528 related articles for article (PubMed ID: 6227711)
21. 99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison.
Lantto T; Vorne M; Mokka R; Vähätalo S
Acta Radiol; 1987; 28(5):631-3. PubMed ID: 2960361
[TBL] [Abstract][Full Text] [Related]
22. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
23. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)].
Honda H; Oshiumi Y; Kamoi I; Ichiya Y; Wada M; Matsuura K
Kaku Igaku; 1981 Nov; 18(9):1315-9. PubMed ID: 6461790
[No Abstract] [Full Text] [Related]
24. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
Nakano S; Hasegawa Y; Shiomura K; Ibuka K; Hashizume T
Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789
[No Abstract] [Full Text] [Related]
25. Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals.
Worsley DF; Lentle BC
J Nucl Med; 1993 Sep; 34(9):1612-5. PubMed ID: 8355083
[No Abstract] [Full Text] [Related]
26. A clinical comparison of MDP and DMAD.
Rosenthall L; Stern J; Arzoumanian A
Clin Nucl Med; 1982 Sep; 7(9):403-6. PubMed ID: 6214358
[TBL] [Abstract][Full Text] [Related]
27. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)].
Ishii C; Mori Y; Hata Y; Katsuyama N; Fujioka M; Fukazawa W; Hashimoto H; Horiuchi T; Fujioka M; Kawakami K
Radioisotopes; 1981 Jul; 30(7):401-3. PubMed ID: 7323328
[No Abstract] [Full Text] [Related]
28. A crossover study comparing Tc-99m-labeled HMDP and MDP in patients.
Rosenthall L; Arzoumanian A; Damtew BU; Tremblay J
Clin Nucl Med; 1981 Aug; 6(8):353-5. PubMed ID: 6455231
[No Abstract] [Full Text] [Related]
29. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
[TBL] [Abstract][Full Text] [Related]
30. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
Okahashi S; Ishimaru T; Maeda H; Sakata T; Yamasaki K; Akagi H
Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
[No Abstract] [Full Text] [Related]
31. [Extraosseous tumor uptake of 99m technetium methylendiphosphonate in children with neuroblastoma (author's transl)].
Mancini AF; Turba E; Vallicelli R; Vitelli A; Fini A; Rosito P
Pediatr Med Chir; 1981; 3(6):535-9. PubMed ID: 6211661
[No Abstract] [Full Text] [Related]
32. The visualization of femoral vessels in delayed bone scans--a sign of arteriosclerosis? A comparison of 99mTc-MDP and 99mTc-DPD.
Lantto T; Järvi K; Toivio I; Vähätalo S; Vorne M
Eur J Nucl Med; 1989; 15(5):265-8. PubMed ID: 2759127
[TBL] [Abstract][Full Text] [Related]
33. [Bone scintigraphy with Tc 99m MDP in the study of late complications of total hip prosthesis].
Tarozzi C; Furno A; Fagioli G; Arguello JM; Miglietta A; Specchia L; Ruggieri N; Rimondi E; De Benedittis M; Galletti S
Chir Organi Mov; 1984; 69(1):57-64. PubMed ID: 6237892
[No Abstract] [Full Text] [Related]
34. [Horseshoe kidney incidentally detected by 99mTc-MDP bone scintigraphy: report of 2 cases (author's transl)].
Bussaka H; Takahashi M
Rinsho Hoshasen; 1982 May; 27(5):581-3. PubMed ID: 6213796
[No Abstract] [Full Text] [Related]
35. 99m-Tc HMDP bone scintigraphic findings of gouty arthropathy of both hands: extending soft tissue uptake adjacent to the joints.
Shih WJ; Purcell M; Domstad PA; DeLand FH
Radiat Med; 1988; 6(1):9-11. PubMed ID: 3413289
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning].
Yang JS
Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062
[No Abstract] [Full Text] [Related]
37. [A new bone scanning agent: clinical experience of 99mTc-hydroxymethane diphosphonate (HMDP) (author's transl)].
Fukunaga M; Fujita T; Shigeno C; Morita R; Torizuka K
Kaku Igaku; 1981 Jul; 18(6):863-7. PubMed ID: 7311135
[No Abstract] [Full Text] [Related]
38. [An evaluation of 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) as a new bone scanning agent (author's transl)].
Hayashi M; Takahashi K; Furukawa K; Hazue M; Shibatsuji H; Yasuda N; Tanaka K; Yoshikawa I; Maeda K; Hamada S
Radioisotopes; 1981 Jan; 30(1):38-9. PubMed ID: 7268059
[No Abstract] [Full Text] [Related]
39. [Local findings of renal cell carcinoma on 99m-Tc-DMSA renal, 99m-Tc-MDP bone and 67-Ga-citrate scintigraphies].
Kawamura J; Itoh H; Yoshida O; Fujita T; Fukunaga M; Morita R; Torizuka K
Kaku Igaku; 1982 Apr; 19(3):357-68. PubMed ID: 6290720
[No Abstract] [Full Text] [Related]
40. Amphotericin B therapy: a cause of increased renal uptake of Tc-99m MDP.
Trackler RT; Chinn RY
Clin Nucl Med; 1982 Jun; 7(6):293. PubMed ID: 6211323
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
